Hematology Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hematology Tests Market Report Overview
The hematology tests market size was valued at $1.44 billion in 2023 and will grow at a CAGR of more than 1% from 2023 to 2033. Hematology is the study of blood, specifically the components that make up whole blood. Different disease states can be diagnosed through the study and measurement of blood analytes.
Hematology Tests Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Hematology tests Market Forecast
The hematology tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of hematology tests across labs, which will help in identifying untapped market opportunities. The hematology tests market model also discusses the detailed impact of COVID-19 on the hematology tests market for 2020 and beyond.
Market Size (2023) | $1.44 billion |
CAGR (2023-2033) | >1% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hematology Tests Market Dynamics
Majority of hematology testing is still lab-based, as point of care technology becomes more reliable the hope is to shift focus and integrate POC into healthcare settings. This is mainly due to the low ASP of the test in conjunction with the reliability of results and clinical importance of multiple parameters being readily available. POC testing will see higher adoption rates in specific testing situations including epidemics, and rural area testing. As technology such as wireless and Bluetooth connectivity improves, POC analyzers’ data management will play a crucial role in the adoption of POC testing. GlobalData expects the hematology market to be dominated by lab testing during the forecast period with nominal growth in POC tests.
Buy the Full Report for Additional Hematology Tests Market Dynamics
Hematology Tests Market Segments
The key segments in the hematology tests market are Complete Blood Count (CBC) Tests, Erythrocytes Point of Care (POC) Tests, Hematocrit Point of Care (POC) Tests, Hemoglobin & Hematocrit POC Tests, and Hemoglobin Laboratory Tests. In 2023, the Complete Blood Count (CBC) Tests was the leading hematology test market segment and will continue to retain its market dominance during the projected period.
Hematology Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment-Wise Insights about the Hematology Tests Market Segments
Hematology Tests Market Segmentation by Regions
The key regions in the hematology tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, Europe led the hematology tests market share. There are varying factors contributing to the growth depending on each nation’s economic development.
Hematology Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights in the Hematology Tests Market
Hematology Tests Market – Competitive Landscape
The key companies in the hematology tests market are Sysmex Corp, F. Hoffmann-La Roche Ltd, Danaher Corp, Abbott Laboratories, Horiba Ltd among others. In 2023, Sysmex Corp accounted for the highest hematology tests market share and value.
Hematology Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Hematology Tests Market, Download a Free Sample Report
Segments Covered in this Report.
Hematology Tests Segment Outlook ($ Million, 2015-2033)
- Complete Blood Count (CBC) Tests
- Erythrocytes Point of Care (POC) Tests
- Hematocrit Point of Care (POC) Tests
- Hemoglobin & Hematocrit POC Tests
- Hemoglobin Laboratory Tests
- Hemoglobin Point of Care (POC) Tests
- Platelets Point of Care (POC) Tests
- White Blood Count Point of Care (POC) Tests
Hematology Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
Currently marketed Hematology tests market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total Hematology tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Hematology tests market.
- Competitive dynamics insights and trends provided for the Hematology tests market.
Get in-depth understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sysmex Corp, F. Hoffmann-La Roche Ltd, Danaher Corp, Abbott Laboratories, Horiba Ltd, EKF Diagnostics Holdings Plc, Thermo Fisher Scientific Inc, Siemens AG, and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is important for the following industry:
- CMO executives who must have a deep understanding of the hematology tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on hematology tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving hematology tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the hematology tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific hematology tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
F. Hoffmann-La Roche Ltd
Danaher Corp
Abbott Laboratories
Horiba Ltd
EKF Diagnostics Holdings Plc
Thermo Fisher Scientific Inc
Siemens AG
Others
Frequently asked questions
-
What was the hematology tests market size in 2023?
The hematology tests market size was $1.44 billion in 2023.
-
What will the CAGR of the hematology tests market be during 2023-2033?
The hematology tests will grow at a CAGR of more than 1% during 2023-2033.
-
Which was the leading segment in the hematology tests market in 2023?
Complete Blood Count (CBC) Tests segment was leading the hematology tests market in 2023.
-
Which region held the largest share of the hematology tests market in 2023?
Europe was the largest regional market for hematology tests in 2023.
-
Which are the leading players in the hematology tests market?
The key companies in the hematology tests market are Sysmex Corp, Roche Diagnostics International Ltd, Abbott Laboratories, EKF Diagnostics Holdings Plc, and Horiba Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.